Contact Us
  Search
The Business Research Company Logo
Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Report 2026
Published :July 2026
Pages :250
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Report 2026

Global Outlook – By Device Type (Pulse Oximeters, Cardiac Monitors Or Electrocardiogram Wearables, Respiratory Monitors, Multi-Vital Monitors, Glucose Monitoring Wearables, Sleep Trackers), By Clinical Use (Cardiac Monitoring, Respiratory Monitoring, Glucose Monitoring, Temperature Monitoring, Sudden Infant Death Syndrome Adjunct Monitoring), By Technology (Optical (Photoplethysmography), Electrical (Electrocardiography), Accelerometers, Bio-Impedance), By End-User (Hospitals And Neonatal Intensive Care Units, Pediatric Clinics And Outpatient Centers, Homecare Settings And Caregivers, Ambulatory Surgical Centers) – Market Size, Trends, Strategies, and Forecast to 2035

Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Overview

• Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices market size has reached to $0.61 billion in 2025 • Expected to grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 20.3% • Growth Driver: The Growing Prevalence Of Chronic Pediatric Conditions Is Driving The Market Due To Rising Monitoring Needs • Market Trend: Non-Invasive Wearable Innovation Advancing Pediatric Therapeutic Care Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market?

Food and drug administration (FDA)-cleared pediatric wearable devices are body-worn, non-invasive medical technologies designed for children and adolescents that have undergone regulatory review by the United States Food and Drug Administration to verify their safety, effectiveness, and intended clinical functionality, enabling continuous or intermittent monitoring, diagnosis, or management of physiological parameters within a pediatric population under defined use conditions. These devices are typically utilized in clinical and home settings to support early detection of health abnormalities, facilitate long-term disease management, enhance patient monitoring compliance, and provide healthcare professionals and caregivers with actionable physiological data for informed decision-making. The main device types of food and drug administration (FDA)-cleared pediatric wearable devices include pulse oximeters, cardiac monitors or electrocardiogram wearables, respiratory monitors, multi-vital monitors, glucose monitoring wearables, and sleep trackers. Pulse oximeters refer to wearable medical devices used to continuously measure oxygen saturation and pulse rate in pediatric patients for real-time clinical monitoring. These solutions are used for clinical applications such as cardiac monitoring, respiratory monitoring, glucose monitoring, temperature monitoring, and sudden infant death syndrome adjunct monitoring. They utilize technologies such as optical photoplethysmography, electrical electrocardiography, accelerometers, and bio-impedance, while end users include hospitals and neonatal intensive care units, pediatric clinics and outpatient centers, homecare settings and caregivers, and ambulatory surgical centers.
Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices market report bar graph

What Is The Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Size and Share 2026?

The food and drug administration (FDA)-cleared pediatric wearable devices market size has grown exponentially in recent years.It will grow from $0.61 billion in 2025 to $0.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increasing prevalence of pediatric chronic diseases, rising demand for early diagnostic interventions, limited availability of child-specific medical wearables, growing hospital-based monitoring dependency, increasing awareness of preventive pediatric healthcare.

What Is The Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Growth Forecast?

The food and drug administration (FDA)-cleared pediatric wearable devices market size is expected to see exponential growth in the next few years.It will grow to $1.52 billion by 2030 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to expansion of home-based pediatric healthcare monitoring, increasing adoption of ai-driven predictive health analytics, rising investment in pediatric digital health infrastructure, growing regulatory approvals for wearable medical devices, increasing integration of cloud and iot healthcare ecosystems.Major trends in the forecast period include rising adoption of ai-enabled pediatric wearable diagnostics for real-time health insights, increasing integration of iot-based connected monitoring ecosystems in pediatric care, expansion of cloud-based remote patient monitoring platforms for children, growing use of advanced biosensor miniaturization for improved wearable accuracy, increasing deployment of cybersecurity frameworks for pediatric health data protection.
Research Expert

Book your 30 minutes free consultation with our research experts

Global Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Segmentation

1) By Device Type: Pulse Oximeters, Cardiac Monitors Or Electrocardiogram Wearables, Respiratory Monitors, Multi-Vital Monitors, Glucose Monitoring Wearables, Sleep Trackers 2) By Clinical Use: Cardiac Monitoring, Respiratory Monitoring, Glucose Monitoring, Temperature Monitoring, Sudden Infant Death Syndrome Adjunct Monitoring 3) By Technology: Optical (Photoplethysmography), Electrical (Electrocardiography), Accelerometers, Bio-Impedance 4) By End-User: Hospitals And Neonatal Intensive Care Units, Pediatric Clinics And Outpatient Centers, Homecare Settings And Caregivers, Ambulatory Surgical Centers Subsegments: 1) By Pulse Oximeters: Fingertip Pulse Oximeters, Wrist-Worn Pulse Oximeters, Handheld Pulse Oximeters, Ring-Based Pulse Oximeters 2) By Cardiac Monitors Or Electrocardiogram Wearables: Patch-Based Cardiac Monitors, Chest Strap Heart Monitors, Wearable Holter Monitors, Smart Garment Cardiac Monitors 3) By Respiratory Monitors: Wearable Respiratory Rate Monitors, Chest-Worn Breathing Monitors, Apnea Monitoring Devices, Smart Garment Respiratory Monitors 4) By Multi-Vital Monitors: Integrated Vital Sign Monitoring Wearables, Smart Patch Multi-Vital Monitors, Wrist-Worn Multi-Parameter Monitors, Smart Clothing Multi-Vital Monitors 5) By Glucose Monitoring Wearables: Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices, Implantable Glucose Monitoring Devices, Non-Invasive Glucose Monitoring Wearables 6) By Sleep Trackers: Wearable Sleep Monitoring Bands, Smart Sock Sleep Trackers, Mattress-Integrated Sleep Monitoring Devices, Smart Pajamas And Sleep Garment Trackers, Wrist-Worn Pediatric Sleep Trackers, Sleep And Movement Monitoring Patches, Infant Sleep Position Monitors, Multi-Parameter Sleep Tracking Wearables

What Is The Driver Of The Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market?

The growing prevalence of chronic pediatric conditions is expected to propel the growth of the FDA-cleared pediatric wearable devices market going forward.Chronic pediatric conditions are long-lasting health disorders that affect infants, children, or adolescents and typically persist for three months or more, often requiring ongoing medical care, management, and sometimes lifestyle adjustments.Their increasing prevalence is influenced by multiple factors, including environmental exposures, lifestyle changes such as sedentary behavior and poor dietary patterns, as well as improved diagnosis and awareness.FDA-cleared pediatric wearable devices, such as continuous glucose monitors and cardiac monitoring systems, support real-time physiological tracking and early detection of complications, enabling more proactive disease management and improved treatment adherence.As the burden of chronic conditions rises, healthcare systems and caregivers are increasingly adopting such technologies to enhance patient outcomes and reduce long-term healthcare costs.For instance, in December 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, globally, an estimated 35 million children below five years of age were affected by excess weight in 2024, while more than 390 million individuals aged five to nineteen were overweight in 2022, including around 160 million with obesity.Therefore, the growing prevalence of chronic pediatric conditions is driving the growth of the FDA-cleared pediatric wearable devices market.

Key Players In The Global Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market

Major companies operating in the food and drug administration (fda)-cleared pediatric wearable devices market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Dexcom Inc., Masimo Corporation, Insulet Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Natus Medical Incorporated, Bittium Corporation, Current Health Ltd., Sibel Health Inc., Empatica Inc., Owlet Baby Care Inc., LifeSignals Inc., VitalConnect Inc., Blue Spark Technologies Inc., BioIntelliSense Inc., Nonin Medical Inc., Biobeat Technologies Ltd., Lief Therapeutics Inc., Preventice Solutions Inc.

What Are Latest Mergers And Acquisitions In The Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market?

In February 2026, Natus Sensory, a US-based provider of sensory diagnostics, newborn care solutions, and clinical monitoring technologies, acquired TheraB Medical for an undisclosed amount. With this acquisition, Natus Sensory aims to expand its newborn care portfolio by integrating wearable phototherapy technology, enhancing its therapeutic capabilities and enabling broader delivery of neonatal treatment across hospital and home-care settings. TheraB Medical is a US-based provider of wearable medical devices focused on neonatal jaundice treatment through innovative phototherapy solutions.

Regional Insights

North America was the largest region in the food and drug administration (FDA)-cleared pediatric wearable devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market?

The food and drug administration (FDA)-cleared pediatric wearable devices market consists of sales of products such as temperature monitoring patches, wearable electroencephalography monitoring systems, wearable blood pressure monitoring devices, hydration monitoring wearables, wearable seizure detection devices, posture monitoring wearables, and wearable movement and activity tracking devices for clinical use. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Industry?

The food and drug administration (fda)-cleared pediatric wearable devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the food and drug administration (fda)-cleared pediatric wearable devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Report 2026?

The food and drug administration (FDA)-cleared pediatric wearable devices market research report is one of a series of new reports from The Business Research Company that provides food and drug administration (FDA)-cleared pediatric wearable devices market statistics, including food and drug administration (FDA)-cleared pediatric wearable devices industry global market size, regional shares, competitors with a food and drug administration (FDA)-cleared pediatric wearable devices market share, detailed food and drug administration (FDA)-cleared pediatric wearable devices market segments, market trends and opportunities, and any further data you may need to thrive in the food and drug administration (FDA)-cleared pediatric wearable devices industry. This food and drug administration (FDA)-cleared pediatric wearable devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$0.73 billion
Revenue Forecast In 2035$1.52 billion
Growth RateCAGR of 20.3% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredDevice Type, Clinical Use, Technology, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Key Companies ProfiledAbbott Laboratories, Medtronic plc, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Dexcom Inc., Masimo Corporation, Insulet Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Natus Medical Incorporated, Bittium Corporation, Current Health Ltd., Sibel Health Inc., Empatica Inc., Owlet Baby Care Inc., LifeSignals Inc., VitalConnect Inc., Blue Spark Technologies Inc., BioIntelliSense Inc., Nonin Medical Inc., Biobeat Technologies Ltd., Lief Therapeutics Inc., Preventice Solutions Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us